When you visit our website, information may be stored or recovered on your device, mainly in the form of cookies. We use essential cookies to ensure the website works as it should, and statistical and marketing cookies for audience measurement and content customisation purposes. We rely on Google to store your consent choices and manage the activation of cookies accordingly. For more information on this, please also refer to the Google policy on Business Data Responsibility.
From the Cookie Management Centre, you can set your preferences with respect to the use of cookies: accept or reject certain categories, accept all, or reject all. For detailed information on all cookies used across these three categories, please refer to our Cookie Policy.
Please note that blocking certain cookies may affect your experience and the services offered.
Essential cookies Always active
Essential cookies help the website to work as it should by enabling necessary functionalities, such as navigating between pages and accessing secure areas. These cannot be disabled in our systems.
Statistical cookies
Statistical cookies help us understand how visitors interact with our site by collecting and communicating browsing information. They make it possible to identify the most and least visited pages and to improve the overall performance of the site.
Marketing cookies
Marketing cookies are used to display relevant advertising and measure the performance of campaigns. If you choose not to allow these cookies, you will continue to see ads, but they will be less relevant to your interests.
Choose the purposes for which we may use Google products to collect and use your data:
User storage: to technically permit advertising functionality.
User data for advertising: to optimise our advertising campaigns.
Ad customisation: to tailor advertising to your interests.
Bloom Biorenewables Ltd., based in Marly, Switzerland, announced the completion of a CHF 13 million series A funding round. This significant investment was led by Anaïs Ventures and Valquest Partners, with participation from several notable investors, including Breakthrough Energy Ventures, Lombard Odier Investment Managers, Capital Risque Fribourg, Btomorrow Ventures, Amcor Ventures, Rosebrook and The King Baudouin Foundation, on behalf of R&Co4Generations, the Rothschild & Co. philanthropic fund.
"We are incredibly grateful for the support from our investors and excited about the opportunities this funding brings," said Remy Buser and Florent Héroguel, Co-CEOs of Bloom Biorenewables. "With this investment, we are well-positioned to advance our technology and bring our sustainable solutions to market. Our AAF technology represents a significant leap forward in biomass upgrading, and we are eager to demonstrate its potential to transform the industry."
At the heart of Bloom Biorenewables' technology is their groundbreaking Aldehyde-Assisted Fractionation (AAF) process, developed at the Laboratory of Sustainable and Catalytic Processing (LPDC) at EPFL. This innovative technology efficiently separates the cellulose fraction while stabilising lignin polymers and hemicellulose-derived sugars. By stabilising these structures, Bloom Biorenewables can fully valorise lignin and hemicellulose for the first time. This breakthrough is set to disrupt the field of biomass upgrading, offering new pathways for converting plant material into high-value chemicals and materials.
The urgency of finding new technologies to leverage renewable carbon cannot be overstated. As the world grapples with the climate crisis, the need for sustainable and renewable solutions is more pressing than ever. Advanced technologies to use renewable carbon, such as those developed by Bloom Biorenewables, are essential in reducing emissions and transitioning to a more sustainable economy. By investing in innovative solutions like AAF, we can accelerate the deployment of cutting-edge technologies and make significant strides towards a carbon-neutral future.
Path to Commercialisation
The new funding will be used over the coming years to scale the AAF process and engineer the first-of-a-kind (FOAK) commercial-scale units, while accelerating market entry. This investment marks a pivotal step in the company's mission to revolutionise the materials industry and contribute to a more sustainable future.
“We have been impressed by the potential of Bloom’s chemistry”, says Julien Firmenich, CEO of Anaïs Ventures. “We are delighted to support the team in their ambitious endeavor to develop and commercialise breakthrough sustainable products.”
“This investment embodies our commitment to empowering visionary companies that are revolutionising the field of sustainable chemistry”, added Fadi Noureddine and Walid Sfeir, Founders and Managing Partners of Valquest Partners. “We are delighted to invest in Bloom, inspired by its pioneering work with Aldehyde-Assisted Fractionation (AAF) technology, and we do look forward to supporting its on-going innovation and leadership in biomass upgrading. This partnership aligns seamlessly with our forward-thinking vision to accelerate the development and scaling of transformative sustainable Greentech solutions”.
subscribe to LOIM investment insights and strategy reports
click here
important information.
For professional investors use only
This document is a Corporate Communication for Professional Investors only and is not a marketing communication related to a fund, an investment product or investment services in your country. This document is not intended to provide investment, tax, accounting, professional or legal advice.